NEWS

Press Releases

Human Longevity, Inc. Announces Kurt Oreshack as General Counsel

(SAN DIEGO, CA) July 8, 2015—Human Longevity, Inc. (HLI), the genomics based, technology driven company, announced today that Kurt Oreshack has been hired as General Counsel.  With degrees in law and philosophy with a focus on medical ethics, Oreshack brings years of experience as a corporate and securities attorney to help guide HLI’s pioneering healthcare work.

(more…)

Media Contact

Heather Kowalski
hkowalski@humanlongevity.com
858-361-0466

Media Resources

HLI Fact Sheet
HLI FAQ

Tweets

NEWS

Press Releases

Human Longevity, Inc. Announces Research Fellows Program

Program Gives Experts from Several Disciplines Unique Opportunity to Advance Human Genomic Understanding

Application Deadline is September 1, 2015

LA JOLLA, CA – Human Longevity, Inc. (HLI), the genomics-based, technology-driven company, announced today the HLI Research Fellows Program, designed to engage experts in the fields of genomics, informatics/bioinformatics, and machine learning to explore the latest findings and knowledge on genetics with clinically relevant outcomes.  The program gives scholars a unique opportunity to participate in innovative analysis of large scale genome data and to work with groups of scientists, bioinformaticians and machine learning specialists to ensure state-of-the-art annotation and interpretation of the human genome.

(more…)

Media Contact

Heather Kowalski
hkowalski@humanlongevity.com
858-361-0466

Media Resources

HLI Fact Sheet
HLI FAQ

Tweets

NEWS

Press Releases

Human Longevity, Inc. and Cleveland Clinic Establish Broad Collaboration in Human Genomics

Initial work will focus on Cleveland Clinic GeneBank study

(LA JOLLA, CA and CLEVELAND, OH) May 14, 2015—Human Longevity, Inc. (HLI) and Cleveland Clinic today announced a broad collaboration agreement to first sequence and analyze blood samples from Cleveland Clinic’s GeneBank study of de-identified patients.

(more…)

Media Contact

Heather Kowalski
hkowalski@humanlongevity.com
858-361-0466

Media Resources

HLI Fact Sheet
HLI FAQ

Tweets

NEWS

Press Releases

Human Longevity, Inc. Receives CLIA Certification

(SAN DIEGO, CA) April 28, 2015 – Human Longevity, Inc. (HLI), the genomic-driven health information technology company, today announced that the company has received certification under the Clinical Laboratory Improvement Amendments of 1988 (CLIA). Under the “deemed status” provision of the U.S. Department of Health and Human Services’ (HHS) Center for Medicare and Medicaid Services (CMS), the state of California has granted the company’s initial CLIA clinical laboratory license.

(more…)

Media Contact

Heather Kowalski
hkowalski@humanlongevity.com
858-361-0466

Media Resources

HLI Fact Sheet
HLI FAQ

Tweets

NEWS

Press Releases

Human Longevity, Inc. Signs Agreement with Genentech for Whole Genome Sequencing and Analysis of Samples

(LA JOLLA, CA) January 14, 2015—Human Longevity, Inc. (HLI), the human health information technology and health care company, today announced a multi-year agreement with Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), to conduct whole genome sequencing of tens of thousands of de-identified samples from Genentech. HLI, using proprietary tools and unique expertise, will sequence genomes to 30x coverage and analyze the data. Financial details of the agreement were not disclosed.

(more…)

Media Contact

Heather Kowalski
hkowalski@humanlongevity.com
858-361-0466

Media Resources

HLI Fact Sheet
HLI FAQ

Tweets

NEWS

Partner Releases

Personal Genome Diagnostics, Inc. and Human Longevity, Inc. Sign Cancer Genomics Agreement

HLI Licenses PGDx’s Suite of Cancer Solutions to Expand the Company’s Cancer Genomics Offering

HLI to Perform Whole Genome Sequencing for PGDx

(more…)

Media Contact

Heather Kowalski
hkowalski@humanlongevity.com
858-361-0466

Media Resources

HLI Fact Sheet
HLI FAQ

Tweets

NEWS

Press Releases

Human Longevity, Inc. Signs Collaborative Agreement with King’s College London to Access TwinsUK Registry

HLI Team and Professor Tim Spector, M.D., to Collaborate Using this Unique Registry of more than 11,000 well-Characterized Twins

(LA JOLLA, CA) November 13, 2014—Human Longevity, Inc. (HLI), a biological data-driven human health technology and cell therapy company, today announced a collaborative agreement with King’s College London to access their TwinsUK Registry.

(more…)

Media Contact

Heather Kowalski
hkowalski@humanlongevity.com
858-361-0466

Media Resources

HLI Fact Sheet
HLI FAQ

Tweets

NEWS

Press Releases

Human Longevity, Inc. Hires Industry Experts Barry Merriman, Ph.D., and Paul Mola, M.S. to Lead New Global Solutions Initiative

(LA JOLLA, CA) October 31, 2014—Human Longevity, Inc. (HLI), a biological data-driven human health technology and cell therapy company, today announced the addition of Barry Merriman, Ph.D., as Vice President of Global Technology Assessment and Paul Mola, M.S. as Head of Global Solutions. The two will work together in HLI’s new Global Solutions Initiative to seek strategic business opportunities worldwide.

(more…)

Media Contact

Heather Kowalski
hkowalski@humanlongevity.com
858-361-0466

Media Resources

HLI Fact Sheet
HLI FAQ

Tweets

NEWS

Partner Releases

Human Longevity Inc. Adds PacBio(R) Sequencing to Enable Additional Insight Into Human Genetic Variation

Purchase of Two PacBio RS II Sequencing Systems Will Be Used to Help Build HLI’s Genotype/Phenotype Database

Media Contact

Heather Kowalski
hkowalski@humanlongevity.com
858-361-0466

Media Resources

HLI Fact Sheet
HLI FAQ

Tweets

NEWS

Press Releases

Human Longevity, Inc. and Celgene Cellular Therapeutics Sign License Agreement to Develop and Commercialize Placental Stem Cell Population, PSC-100 for Multiple Therapeutic Applications

Celgene Makes Equity Investment in HLI

(LA JOLLA, CA) August 11, 2014—Human Longevity, Inc. (HLI), a genomics and cell therapy-based diagnostic and therapeutic company focused on extending the healthy, high performance human life span, today announced it has signed an agreement with Celgene Cellular Therapeutics (CCT) to license, develop, and co-promote Celgene’s proprietary placental cell population, PSC-100.

(more…)

Media Contact

Heather Kowalski
hkowalski@humanlongevity.com
858-361-0466

Media Resources

HLI Fact Sheet
HLI FAQ

Tweets